Showing results (1491-1500 of 2,623) with videos related to

Sort By:
Pageof 263
Aging & Mental Health|June 15, 2007
Initial psychometrics of the ambiance scale: a tool to study person-environment interaction in dementiaDonna L Algase, Lan Yao, Gwi-Ryung S Hong, et al.
The British Journal of Radiology|June 24, 2009
Enhancement pattern of the normal facial nerve at 3.0 T temporal MRIH S Hong, B-H Yi, J-G Cha, et al.
Biology of Reproduction|September 11, 2009
Molecular cloning and functional characterization of a zebrafish nuclear progesterone receptorShi X Chen, Jan Bogerd, Angel García-López, et al.
Cancer Gene Therapy|February 8, 2020
Non-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumorsJason Whitt, Won S Hong, Rahul R Telange, et al.
Langenbeck'S Archives of Surgery|August 21, 2012
The novel orally active guanylhydrazone CPSI-2364 prevents postoperative ileus in mice independently of anti-inflammatory vagus nerve signalingS Wehner, T O Vilz, N Sommer, et al.
Investigational New Drugs|December 1, 1987
In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assayY Sasaki, F Kanzawa, H Takahashi, et al.
The Permanente Journal|June 26, 2025
Comparing Care Delivery Efficiency Between Emergency Department and Oncology Urgent CareArthur S Hong, Sadaf Charania, Angela Bazzell, et al.
Nature Nanotechnology|March 25, 2014
Subnanometre resolution in three-dimensional magnetic resonance imaging of individual dark spinsM S Grinolds, M Warner, K De Greve, et al.
Oncogene|January 1, 1990
Stimulation of adrenal medullary cells in vivo and in vitro induces expression of c-fos proto-oncogeneM K Stachowiak, M Sar, R K Tuominen, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 5, 2021
Translational pharmacokinetic-pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II doseWenyuan Xiong, Manja Friese-Hamim, Andreas Johne, et al.
Pageof 263